JP2023099092A5 - - Google Patents

Download PDF

Info

Publication number
JP2023099092A5
JP2023099092A5 JP2023073005A JP2023073005A JP2023099092A5 JP 2023099092 A5 JP2023099092 A5 JP 2023099092A5 JP 2023073005 A JP2023073005 A JP 2023073005A JP 2023073005 A JP2023073005 A JP 2023073005A JP 2023099092 A5 JP2023099092 A5 JP 2023099092A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
cancer
cargo
modification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023073005A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023099092A (ja
Filing date
Publication date
Priority claimed from JP2021541011A external-priority patent/JP2022513311A/ja
Application filed filed Critical
Publication of JP2023099092A publication Critical patent/JP2023099092A/ja
Publication of JP2023099092A5 publication Critical patent/JP2023099092A5/ja
Pending legal-status Critical Current

Links

JP2023073005A 2018-09-21 2023-04-27 カーゴ積載細胞外小胞 Pending JP2023099092A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862734303P 2018-09-21 2018-09-21
US62/734,303 2018-09-21
JP2021541011A JP2022513311A (ja) 2018-09-21 2018-12-06 カーゴ積載細胞外小胞

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021541011A Division JP2022513311A (ja) 2018-09-21 2018-12-06 カーゴ積載細胞外小胞

Publications (2)

Publication Number Publication Date
JP2023099092A JP2023099092A (ja) 2023-07-11
JP2023099092A5 true JP2023099092A5 (cg-RX-API-DMAC10.html) 2024-01-25

Family

ID=69887709

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021541011A Pending JP2022513311A (ja) 2018-09-21 2018-12-06 カーゴ積載細胞外小胞
JP2023073005A Pending JP2023099092A (ja) 2018-09-21 2023-04-27 カーゴ積載細胞外小胞

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021541011A Pending JP2022513311A (ja) 2018-09-21 2018-12-06 カーゴ積載細胞外小胞

Country Status (3)

Country Link
US (1) US20210355492A1 (cg-RX-API-DMAC10.html)
JP (2) JP2022513311A (cg-RX-API-DMAC10.html)
WO (1) WO2020060479A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021145821A1 (en) 2020-01-13 2021-07-22 Carmine Therapeutics Pte. Ltd. Nucleic acid loaded red blood cell extracellular vesicles
WO2021212066A2 (en) * 2020-04-17 2021-10-21 Ohio State Innovation Foundation Rbc extracellular vesicles
CN117202894A (zh) * 2021-03-31 2023-12-08 胭脂红治疗私人有限公司 负载至少两个不同核酸的细胞外囊泡
IT202100027725A1 (it) * 2021-10-28 2023-04-28 Torino Politecnico Metodo per l’ottenimento di popolazioni concentrate di vescicole extracellulari lavate del loro carico fisio-patologico
JP2024540165A (ja) * 2021-11-01 2024-10-31 シグマ-アルドリッチ・カンパニー・リミテッド・ライアビリティ・カンパニー Crispr-casシステムのためのエレクトロポレーションエンハンサー
CN116763817A (zh) * 2022-03-08 2023-09-19 中山大学 血液来源的样品在制备囊泡中的应用
WO2023172208A1 (en) * 2022-03-11 2023-09-14 National University Of Singapore Vesicle-based compositions and uses thereof
CN117126888A (zh) * 2023-06-21 2023-11-28 安徽省立医院(中国科学技术大学附属第一医院) 装载蛋白或多肽的细胞外囊泡递送平台及其应用
IT202300026244A1 (it) * 2023-12-07 2025-06-07 Univerista Degli Studi Di Urbino Carlo Bo Vescicole extracellulari derivate da globuli rossi caricate con molecole di carico per applicazioni terapeutiche e metodo di produzione delle stesse

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329161B2 (en) * 2008-05-01 2012-12-11 National Health Research Institutes Red blood cell-derived vesicles as a nanoparticle drug delivery system
ES2362589B1 (es) * 2009-12-28 2012-05-16 Centre De Recerca En Salut Internacional De Barcelona Exosomas derivados de reticulocitos infectados con plasmodium sp., método para su obtención y su uso.
CN111206032B (zh) * 2013-12-12 2024-07-19 布罗德研究所有限公司 用于基因组编辑的crispr-cas系统和组合物的递送、用途和治疗应用
WO2016187717A1 (en) * 2015-05-26 2016-12-01 Exerkine Corporation Exosomes useful for genome editing
RU2763524C2 (ru) * 2015-06-03 2021-12-30 Инновекс Терапеутикс, С.Л. Экзосомы и их применение в качестве вакцины
US10914748B2 (en) * 2016-09-08 2021-02-09 UNIVERSITé LAVAL Erythrocyte-derived extracellular vesicles as a biomarker for clinically assessing Parkinson's disease
AU2017335084B2 (en) * 2016-09-30 2023-06-29 Ilias Biologics Inc. Compositions containing protein loaded exosome and methods for preparing and delivering the same

Similar Documents

Publication Publication Date Title
JP7506670B2 (ja) 脂質ナノ粒子製剤
UA130104C2 (uk) Композиції на основі ліпідних наночастинок
US20240132890A1 (en) Nucleic acid molecules for pseudouridylation
US20240218354A1 (en) Guide rnas with chemical modification for prime editing
CN115666659A (zh) 稳定性增加的修饰的寡核苷酸的合成
WO2024084048A1 (en) Heteroduplex rna editing oligonucleotide complexes
CN120129532A (zh) 稳定的脂质或类脂质纳米颗粒悬浮液
US20200190513A1 (en) Methods and systems for analyzing guide rna molecules
US11987791B2 (en) Compositions and methods for modulating hepatocyte nuclear factor 4-alpha (HNF4α) gene expression
JP2014527401A5 (cg-RX-API-DMAC10.html)
JP2005500025A5 (cg-RX-API-DMAC10.html)
WO2023288111A2 (en) Polynucleotide compositions and methods for gene expression regulation
KR20130051954A (ko) 베타-ENaC-관련 질환을 치료하기 위한 유기 조성물
CA3159799A1 (en) Engineering circular guide rnas
US20240254462A1 (en) Compositions and methods for modulating secreted frizzled receptor protein 1 (sfrp1) gene expression
CN116096886A (zh) 用于调节叉头框p3(foxp3)基因表达的组合物和方法
JP2024524974A (ja) ナンセンス変異依存rna分解機構に基づく病態及び疾患の処置のためのアンチセンスオリゴマー
CN102178959B (zh) 抑制肺转移肿瘤生长的siRNA及其寡聚核酸组合与应用
CN121127248A (zh) 用于抑制线粒体偕胺肟还原组分1 (MARC1)表达的RNAi剂、其药用组合物及使用方法
WO2025259863A1 (en) Thermostable ribonuclease r for circular rna purification
EP4716741A2 (en) Compositions and methods for reducing cxcl9, cxcl10, and cxcl11 gene expression
JP2026068029A (ja) 一本鎖核酸及びその用途
WO2025227122A1 (en) Adipose-selective branched rna compounds
WO2024220934A1 (en) Nucleic acid molecules for pseudouridylation
US20060040290A1 (en) Methods, compositions, and kits comprising PNA for RNA interference